genedrive plc (LON:GDR – Get Free Report) shares rose 10.7% during trading on Wednesday . The stock traded as high as GBX 3.40 ($0.04) and last traded at GBX 3.35 ($0.04). Approximately 20,431,723 shares traded hands during mid-day trading, an increase of 37% from the average daily volume of 14,922,010 shares. The stock had previously closed at GBX 3.03 ($0.04).
genedrive Price Performance
The company has a quick ratio of 5.52, a current ratio of 1.63 and a debt-to-equity ratio of 8.57. The business has a 50-day moving average price of GBX 2.43 and a two-hundred day moving average price of GBX 3.84. The company has a market capitalization of £5.48 million, a price-to-earnings ratio of -81.18 and a beta of 0.04.
genedrive Company Profile
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Read More
- Five stocks we like better than genedrive
- How to Invest in Small Cap Stocks
- What Are Bonds? A High-Level Overview
- The 3 Best Retail Stocks to Shop for in August
- Super Micro Stock Drops Sharply After Earnings on Margin Concerns
- Why Invest in High-Yield Dividend Stocks?
- Lyft’s First-Ever Profit, but the Outlook Is a Speed Bump
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
